AAD  Vol.6 No.4 , December 2017
Experimental Analysis of Interacting HT22 Plasma Membrane Cholesterol and β-Amyloid
Abstract: The peptide β-Amyloid (β-A) is known to be one of the primary factors causing neurodegeneration in the Alzheimer disease. Hence, one would like to know the factors that would increase or decrease the toxicity of β-Amyloid in the brain. One of the factors that are debated in the literature is cholesterol, where it is not clear if modulating the levels of cholesterol would affect the degree of toxicity of β-Amyloid on neuron cells in the brain. In order to investigate this problem, data were collected and analyzed for three types of experiments: 1) Correspondence between cholesterol and methyl-β-cyclodextrin (MβCD) measurements; 2) measurements of the relative fluorescence unit (RFU) with respect to MβCD concentration (with/without β-A); and 3) RFU measurements with respect to β-A concentration (with/without MβCD). HT22 hippocampal neurons immortalized with the simian virus SV-40 large T-antigen plasmid vector were used to conduct the experiments. Mito-ID Membrane potential cytotoxicity was used as a measure of mitochondrial potential change. The statistical analysis of the presented experimental results indicates that cholesterol has no statistically significant effect on the degree of toxicity of β-Amyloid.
Cite this paper: Livadiotis, G. , Assas, L. , Dayeh, M. , Elaydi, S. , Phea, C. , Roberts, J. , Samman, Y. and Tchen, R. (2017) Experimental Analysis of Interacting HT22 Plasma Membrane Cholesterol and β-Amyloid. Advances in Alzheimer's Disease, 6, 75-96. doi: 10.4236/aad.2017.64006.

[1]   Edland, S.D., Slager, S. and Farrer, M. (2004) Genetic Association Studies in Alzheimer’s Disease Research: Challenges and Opportunities. Statistics in Medicine, 23, 169-178.

[2]   Pollard, H.B., Arispe, N. and Rojas, E. (1995) Ion Channel Hypothesis for Alzheimer Amyloid Peptide Neurotoxicity. Cellular and Molecular Neurobiology, 15, 513-526.

[3]   Butterfield, S.M. and Lashuel, H.A. (2010) Amyloidogenic Protein-Membrane Interactions: Mechanistic Insight from Model Systems. Angewandte Chemie International Edition, 49, 5628-5654.

[4]   Williams, T.L. and Serpell, L.C. (2011) Membrane and Surface Interactions of Alzheimer’s β-A Peptide-Insights into the Mechanism of Cytotoxicity. FEBS Journal, 278, 3905-3917.

[5]   Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J. and Lal, R. (2005) Amyloid Ion Channels: A Common Structural Link for Protein-Misfolding Disease. PNAS, 102, 10427-10432.

[6]   Connelly, L., Arc, F.T., Jang, H., Capone, R., Kotler, S., Ramachsaandran, S., Kagan, B., Nussinov, R. and Lal, R. (2012) Atomic Force Microscopy and MD Simulations Reveal Pore-Like Structures of all-D-enantiomer of Alzheimer’s β-Amyloid Peptide: Relevance to the Ion Channel Mechanism of AD Pathology. The Journal of Physical Chemistry B, 116, 1728-1735.

[7]   Kayed, R., Head, E., Thompson, J.L., McIntire, T.M., Milton, S.C., Cotman, C.W. and Glabe, C.G. (2003) Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis. Science, 300, 486-489.

[8]   Demuro, A., Mina, E., Kayed, R., Milton, S.C., Parker, I. and Glabe, C.G. (2005) Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers. The Journal of Biological Chemistry, 280, 17294-17300.

[9]   Van Meer, G., Voelker, D.R. and Feigenson, G.W. (2008) Membrane Lipids: Where They Are and How They Behave. Nature Reviews Molecular Cell Biology, 9, 112-124.

[10]   Simons, M., Keller, P., Destrooper, B., Beyreuther, K., Dotti, C.G. and Simons, K. (1998) Cholesterol Depletion Inhibits the Generation of Beta-Amyloid in Hippocampal Neurons. PNAS, 95, 6460-6464.

[11]   Rushworth, J.V. and Hooper, N.M. (2011) Lipid Rafts: Linking Alzheimer’s Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes. International Journal of Alzheimer’s Disease, 2011, Article ID: 603052.

[12]   Sorensen, A.A. and Weedon, D. (2016) The Top 100 Cited Cholesterol Papers. Biomedical Spectroscopy and Imaging, 5, S5-S43.

[13]   Vance, J.E., Hayashi, H. and Karen, B. (2005) Cholesterol Homeostasis in Neurons and Glial Cells. Seminars in Cell & Developmental Biology, 16, 193-212.

[14]   Romano, T.A., Ridgway, S.H., Felten, D.L. and Quaranta, V. (1999) Molecular Cloning and Characterization of CD4 in an Aquatic Mammal, the White Whale Delphinapterus leucas. Immunogenetics, 49, 376-383.

[15]   Jarvik, G.P. (1998) Complex Segregation Analyses: Uses and Limitations. The American Journal of Human Genetics, 63, 942-946.

[16]   Evans, R.M., Emsley, C.L., Gao, S., Sahota, A., Hall, K.S., Farlow, M.R. and Hendrie, H. (2000) Serum Cholesterol, APOE Genotype, and the Risk of Alzheimer’s Disease: A Population-Based Study of African Americans. Neurology, 54, 240-242.

[17]   Kivipelto, M., Laasko, M.P., Tuomilehto, J., Nissinen, A. and Soininen, H. (2002) Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer’s Disease: Potential for Pharmacological Intervention. CNS Drugs, 16, 435-444.

[18]   Anstey, K.J., Ashby-Mitchell, K. and Peters, R. (2017) Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis. Journal of Alzheimer’s Disease, 56, 215-228.

[19]   Arispe, N., Pollard, H.B. and Rojas, E. (1994) Beta-Amyloid Ca(2+)-channel Hypothesis for Neuronal Death in Alzheimer Disease. Molecular and Cellular Biochemistry, 140, 119-125.

[20]   Cecchi, C., Nichino, D., Zampagni, M., Bernacchioni, C., Evangelisti, E., Pensalfini, A., Liguri, G., Gliozzi, A., Stefani, M. and Relini, A. (2009) A Protective Role for Lipid Raft Cholesterol against Amyloid-Induced Membrane Damage in Human Neuroblastoma Cells. Biochimica et Biophysica Acta, 1788, 2204-2216.

[21]   Schneider, A., Schulz-Schaeffer, W., Hartmann, T., Schulz, J.B. and Simons, M. (2006) Cholesterol Depletion Reduces Aggregation of Amyloid-Beta Peptide in Hippocampal Neurons. Neurobiology of Disease, 23, 573-577.

[22]   De Chaves, E. (2012) Lipids in Lipids in Alzheimer’s Disease: A New Link between Cholesterol and a Beta Toxicity. Canadian Journal of Physiology and Pharmacology, 90, 674-675.

[23]   Uranga, R.M. and Keller, J.N. (2010) Diet and Age Interactions with Regards to Cholesterol Regulation and Brain Pathogenesis. Current Gerontology and Geriatrics Research, 2010, Article ID: 219683.

[24]   Brosche, T. and Platt, D. (1990) Decrease of Cholesterol Concentration in Human Erythrocyte Ghosts in Old Age. Experimental Gerontology, 25, 23-28.

[25]   Zhang, J. and Liu, Q. (2015) Cholesterol Metabolism and Homeostasis in the Brain. Protein Cell, 6, 254-264.

[26]   Nicholson, A.M. and Ferreira, A. (2009) Increased Membrane Cholesterol Might Render Mature Hippocampal Neurons More Susceptible to Beta-Amyloid-Induced Calpain Activation and Tau Toxicity. Journal of Neuroscience, 29, 4640-4651.

[27]   Nicholson, A.M., Methner, D.N.R. and Ferreira, A. (2011) Membrane Cholesterol Modulates β-Amyloid-Dependent Tau Cleavage by Inducing Changes in the Membrane Content and Localization of N-Methyl-d-Aspartic Acid Receptors. The Journal of Biological Chemistry, 286, 976-986.

[28]   McKay, R. and DiMaio, D. (1981) Binding of an SV40 T Antigen-Related Protein to the DNA of SV40 Regulatory Mutants. Nature, 289, 810-813.

[29]   Woollacott, A.J. and Simpson, P.B. (2001) High Throughput Fluorescence Assays for the Measurement of Mitochondrial Activity in Intact Human Neuroblastoma Cells. Journal of Biomolecular Screening, 6, 413-420.

[30]   Livadiotis, G. (2007) Approach to General Methods for Fitting and Their Sensitivity. Physica A, 375, 518-536.

[31]   Livadiotis, G. (2014) Chi-p Distribution: Characterization of the Goodness of the Fitting using Lp Norms. Journal of Statistical Distributions and Applications, 1, 4.

[32]   Frisch, P.C., Bzowski, M., Livadiotis, G., McComas, D.J., Mobius, E., Mueller, H.-R., Pryor, W.R., Schwadron, N.A., Sokól, J.M., Vallerga, J.V. and Ajello, J.M. (2013) Decades-Long Changes of the Interstellar Wind through Our Solar System. Science, 341, 1080.

[33]   Livadiotis, G. and McComas, D.J. (2013) Evidence of Large Scale Phase Space Quantization in Plasmas. Entropy, 15, 1118-1132.

[34]   Schwadron, N.A., Mobius, E., Kucharek, H., Lee, M.A., French, J., Saul, L., Wurz, P., Bzowski, M., Fuselier, S., Livadiotis, G., McComas, D.J., Frisch, P., Gruntman, M. and Mueller, H. (2013) Solar Radiation Pressure and Local Interstellar Medium Flow Parameters from IBEX Low Energy Hydrogen Measurements. The Astrophysical Journal, 775, 86.

[35]   Fuselier, S.A., Allegrini, F., Bzowski, M., Dayeh, M.A., Desai, M., Funsten, H.O., Galli, A., Heirtzler, D., Janzen, P., Kubiak, M.A., Kucharek, H., Lewis, W., Livadiotis, G., McComas, D.J., Mobius, E., Petrinec, S.M., Quinn, M., Schwadron, N., Sokól, J.M., Trattner, K.J., Wood, B.E. and Wurz, P. (2014) Low Energy Neutral Atoms from the Heliosheath. The Astrophysical Journal, 784, 89.

[36]   Livadiotis, G. and Moussas, X. (2007) The Sunspot as an Autonomous Dynamical System: A Model for the Growth and Decay Phases of Sunspots. Physica A, 379, 436-458.

[37]   Dayeh, M., Assas, L., Aminian, F., Cheng, K.M., Elaydi, S., Livadiotis, G., Moreno, V., Viswasam, N. and Roberts, J.L. (2017) The Role of Cholesterol in Stress Related Neuronal Death.

[38]   He, M., Liu, J., Cheng, S., Xing, Y. and Suo, W.Z. (2013) Differentiation Renders Susceptibility to Excitotoxicity in HT22 Neurons. Neural Regeneration Research, 8, 1297-1306.

[39]   Suo, Z., Wu, M., Citron, B.A., et al. (2003) Rapid Tau Aggregation and Delayed Hippocampal Neuronal Death Induced by Persistent Thrombin Signaling. The Journal of Biological Chemistry, 278, 37681-37689.

[40]   Schaefer, P.M., von Einem, B., Walther, P., Calzia, E. and von Arnim, C.A.F. (2016) Metabolic Characterization of Intact Cells Reveals Intracellular Amyloid Beta but Not Its Precursor Protein to Reduce Mitochondrial Respiration, PLoS ONE, 11, e0168157.